Altimmune (ALT) vs BlossomHill Therapeutics (BLSM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
BlossomHill Therapeutics is the larger company by market cap ($527.9 million vs $517.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALT | BLSM |
|---|---|---|
| Share price | $2.66 | $16.61 |
| Market cap | $517.42M | $527.95M |
| 1-day change | -0.37% | -3.93% |
| YTD return | -26.32% | — |
| 1-year return | -32.32% | — |
| 5-year return | -77.85% | — |
| EPS (TTM) | $-0.76 | $-4.70 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.44 | $27.99 |
| 52-week low | $2.56 | $15.25 |
| Distance from 52-week high | -58.70% | -40.66% |
| Average volume | 4.19M | 263.69K |
| Shares outstanding | 194.52M | 31.78M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ALT vs BLSM FAQ
Which is bigger, Altimmune or BlossomHill Therapeutics?
BlossomHill Therapeutics (BLSM) is larger, with a market capitalization of $527.95M compared with $517.42M for Altimmune (ALT).
Are Altimmune and BlossomHill Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.